PORTLAND, Ore., May 16, 2024 /PRNewswire/ -- Allied Market
Research published a report, titled, "Peripheral Artery Disease
Market by Product Type (Devices and Drugs), and End User (Hospitals
and Specialty Clinics): Global Opportunity Analysis and Industry
Forecast, 2024-2035". According to the report, the
"peripheral artery disease market" was
valued at $4.5 billion in 2023, and
is estimated to reach $10.8
billion by 2035, growing at a CAGR of 7.7% from 2024 to
2035.
Request Sample of the Report on Peripheral Artery Disease
Market Forecast 2035-
https://www.alliedmarketresearch.com/request-sample/4315
Prime determinants of growth
The peripheral artery disease market is expected to grow
significantly owing to rise in the prevalence of peripheral artery
disease, surge in the geriatric population, and rise in the
adoption of minimal invasive procedures. Furthermore,
technological advancement in peripheral artery disease treatment
devices is expected to present significant growth
opportunities in the peripheral artery disease market.
Report coverage & details
Report
Coverage
|
Details
|
Forecast
Period
|
2024–2035
|
Base Year
|
2023
|
Market Size in
2023
|
$4.5 billion
|
Market Size in
2035
|
$10.8
billion
|
CAGR
|
0.077
|
No. of Pages in
Report
|
280
|
Segments
covered
|
Product Type, End User,
and Region
|
Regional
scope
|
North America, Europe,
Asia-Pacific, and LAMEA
|
Country
scope
|
U.S., Canada, Mexico,
Germany, France, the UK, Italy, Spain, Rest of Europe, Japan,
China, India, Australia, South Korea, Rest of Asia-Pacific, Brazil,
Saudi Arabia, South Africa, and Rest of LAMEA
|
Drivers
|
Rise in prevalence of
peripheral artery disease
|
|
Surge in the geriatric
population
|
|
Rise in the adoption of
the minimal invasive procedures
|
Opportunity
|
Technological
advancement in peripheral artery disease treatment
devices
|
Restraint
|
High cost of peripheral
artery disease treatment devices
|
Want to Explore More, Connect to our
Analyst- https://www.alliedmarketresearch.com/connect-to-analyst/4315
The drug segment to maintain its leadership status throughout
the forecast period
By product type, the drug segment held the highest market share
in 2023 and is expected to dominate during the forecast
period, accounting for three-fifths of the peripheral artery
disease market revenue, owing to the regular need of drugs to
control blood cholesterol levels to avoid progression of peripheral
artery disease.
The hospitals segment to maintain its leadership status
throughout the forecast period
By end user, the hospitals segment held the highest market share
in 2023, accounting for more than half of peripheral artery disease
market revenue owing to peripheral artery disease often
requiring complex diagnostic procedures, medical management,
and interventional treatments such as angioplasty, stenting, or
bypass surgery. Hospitals are equipped with the necessary
infrastructure, including specialized imaging facilities, operating
rooms, and skilled medical professionals, to deliver these
treatments effectively.
However, the specialty clinics segment is expected to register
the highest CAGR during the forecast period, owing to specialty
clinics being typically more efficient and cost-effective than
hospitals for certain peripheral artery disease related services.
With lower overhead costs and streamlined processes, specialty
clinics can provide high-quality care at competitive prices,
appealing to patients and payers alike.
For Purchase Enquiry-
https://www.alliedmarketresearch.com/purchase-enquiry/4315
North America to maintain
its leadership status throughout the forecast period
By region, North America held
the highest market share in 2023, accounting for more than
one-third of peripheral artery disease market revenue. This is
attributed to the strong presence of key players in the
region, well-developed healthcare infrastructure, and rise in
the prevalence of peripheral artery disease. However, Asia-Pacific is expected to register a
noteworthy CAGR during the forecast period, owing to rise in the
geriatric population and surge in the prevalence of cardiovascular
disease.
Leading Market Players
- Philips N.V.
- Braun Melsungen AG
- Medtronic
- Bayer AG
- Boston Scientific Corporation
- Becton Dickinson and
Company
- Terumo Medical Corporation
- Biotronik
- Cardinal Health
- Abbott
The report provides a detailed analysis of these key players in
the peripheral artery disease market. These players have adopted
different strategies such as product approval, to increase their
market share and maintain dominant shares in different regions. The
report is valuable in highlighting business performance, operating
segments, product portfolio, and strategic moves of market players
to showcase the competitive scenario
AVENUE- A Subscription-Based Library (Premium on-demand,
subscription-based pricing model) Offered by Allied Market
Research:
AMR introduces its online premium subscription-based library
Avenue, designed specifically to offer cost-effective, one-stop
solution for enterprises, investors, and universities. With Avenue,
subscribers can avail an entire repository of reports on more than
2,000 niche industries and more than 12,000 company profiles.
Moreover, users can get an online access to quantitative and
qualitative data in PDF and Excel formats along with analyst
support, customization, and updated versions of reports.
Get an access to the library of reports at any time from any
device and anywhere. For more details, follow the link:
https://www.alliedmarketresearch.com/library-access
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research
and business-consulting wing of Allied Analytics LLP based in
Wilmington, Delaware. Allied
Market Research provides global enterprises as well as medium and
small businesses with unmatched quality of "Market Research
Reports" and "Business Intelligence Solutions." AMR has a targeted
view to provide business insights and consulting to assist its
clients to make strategic business decisions and achieve
sustainable growth in their respective market domains. AMR offers
its services across 11 industry verticals including Life Sciences,
Consumer Goods, Materials & Chemicals, Construction &
Manufacturing, Food & Beverages, Energy & Power,
Semiconductor & Electronics, Automotive & Transportation,
ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various
companies and this helps us in digging out market data that helps
us generate accurate research data tables and confirms utmost
accuracy in our market forecasting. Allied Market Research CEO
Pawan Kumar is instrumental in
inspiring and encouraging everyone associated with the company to
maintain high quality of data and help clients in every way
possible to achieve success. Each and every data presented in the
reports published by us is extracted through primary interviews
with top officials from leading companies of domain concerned. Our
secondary data procurement methodology includes deep online and
offline research and discussion with knowledgeable professionals
and analysts in the industry.
Contact
David Correa
1209 Orange
Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int'l:
+1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn
Logo:
https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/peripheral-artery-disease-market-to-reach-10-8-billion-globally-by-2035-at-7-7-cagr-allied-market-research-302147426.html